Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability. Blechman SE, Wright ES. PLoS Pathog 2024;20:e1012422.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blechman SE, Wright ES. Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability. PLoS Pathog 2024;20:e1012422.
PMID: 39207957